Objectives

To obtain independent, high precision estimates of the efficacy of standard primaquine therapy when combined with artesunate pyronaridine (AS-PYR) or dihydroartemisinin piperaquine (DHA-PP) for radical cure of acute malaria caused by P. vivax. 

PI Institution(s)

Principal Investigator (PI)

Funding source(s)

Partner(s)